Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
InMed Pharmaceuticals ( (INM) ) has issued an update.
InMed Pharmaceuticals has published a study revealing the potential of cannabinol (CBN) as an anti-inflammatory agent for skin diseases. The research highlights how CBN modulates the endocannabinoid system, showing promise for treating conditions like psoriasis and atopic dermatitis. This development could pave the way for therapeutic and cosmetic applications, underscoring CBN’s role in regulating skin inflammation and offering protective benefits.
Learn more about INM stock on TipRanks’ Stock Analysis page.
